Akari Therapeutics Plc (AKTX)
7.52
-0.33
(-4.20%)
USD |
NASDAQ |
Aug 24, 16:00
7.52
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Debt to Equity Ratio : 0.0373 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0373 |
| March 31, 2026 | 0.0509 |
| December 31, 2025 | 0.0266 |
| September 30, 2025 | 0.0933 |
| June 30, 2025 | 0.0604 |
| March 31, 2025 | 0.0849 |
| December 31, 2024 | 0.1467 |
| September 30, 2024 | -0.1793 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| March 31, 2023 | |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.0733 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| DBV Technologies SA | 0.0784 |
| Cellectis SA | 2.539 |
| argenx SE | -- |
| Autolus Therapeutics Plc | 4.915 |
| Evaxion AS | 0.7455 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 38.62M |
| Total Liabilities (Quarterly) | 20.03M |
| Shareholders Equity (Quarterly) | 18.60M |
| Current Ratio | 0.5973 |
| Net Debt Paydown Yield | 1.29% |